In HCC, METTL3 expression was found to positively correlate with angiogenesis and significantly affect angiogenesis, and in addition, m6A methylation levels also affected HCC stage and prognosis, while negatively regulating tumor response to anti-angiogenic drugs [200, 201]. This evidence concerns the gene METTL3 and neoplasm.